# FDA Inspection 1030300 - Grifols Biologicals LLC - August 22, 2017

Source: https://www.keypedia.com/records/fda_inspections/grifols-biologicals-llc/7d95babc-3ded-46f0-acd7-59b29a125b36
Source feed: FDA_Inspections

> FDA Inspection 1030300 for Grifols Biologicals LLC on August 22, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1030300
- Company Name: Grifols Biologicals LLC
- Inspection Date: 2017-08-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1239092 - 2024-09-10](https://www.keypedia.com/records/fda_inspections/grifols-biologicals-llc/ef61cb14-0dd8-4b4b-abad-0405939df44a)
- [FDA Inspection 1239092 - 2024-09-10](https://www.keypedia.com/records/fda_inspections/grifols-biologicals-llc/95361a97-f098-4c1b-939f-550752ddd311)
- [FDA Inspection 1107183 - 2019-09-12](https://www.keypedia.com/records/fda_inspections/grifols-biologicals-llc/b76dd2e2-5521-4e67-a44f-372ef07735fa)
- [FDA Inspection 945099 - 2015-10-16](https://www.keypedia.com/records/fda_inspections/grifols-biologicals-llc/406c5b56-c090-4041-8fff-8ee4b69deee5)

Company: https://www.keypedia.com/companies/grifols-biologicals-llc/206a08df-1e93-4280-b926-83661b2bb985

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d